Drug Shortage Report for BLEPHAMIDE
| Report ID | 137389 |
| Drug Identification Number | 00807788 |
| Brand name | BLEPHAMIDE |
| Common or Proper name | sulfacetamide/prednisolone |
| Company Name | ALLERGAN INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | SULFACETAMIDE SODIUM PREDNISOLONE ACETATE |
| Strength(s) | 10% 0.2% |
| Dosage form(s) | DROPS |
| Route of administration | OPHTHALMIC OPHTHALMIC |
| Packaging size | 5ml and 10ml |
| ATC code | S01CA |
| ATC description | ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2021-04-13 |
| Estimated end date | 2021-05-21 |
| Actual end date | 2021-05-25 |
| Shortage status | Resolved |
| Updated date | 2021-07-30 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2021-07-30 | French | Compare |
| v7 | 2021-07-30 | English | Compare |
| v6 | 2021-06-23 | English | Compare |
| v5 | 2021-05-18 | French | Compare |
| v4 | 2021-05-18 | English | Compare |
| v3 | 2021-04-14 | English | Compare |
| v2 | 2021-04-13 | French | Compare |
| v1 | 2021-04-13 | English | Compare |
Showing 1 to 8 of 8